Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy SVB Leerink LLC

Vertex Pharmaceuticals Inc.
Start price
€330.00
25.09.25 / 50%
Target price
€388.33
25.09.26
Performance (%)
38.27%
Price
€456.30
12.08.26
Summary
This prediction is currently active. With a performance of 38.27% the BUY prediction by SVB_Leerink_LLC is a big success. This prediction currently runs until 25.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Vertex Pharmaceuticals Inc. 8.656% 8.656%
iShares Core DAX® 0.184% 5.072%
iShares Nasdaq 100 -0.770% -2.079%
iShares Nikkei 225® 0.733% -3.346%
iShares S&P 500 -0.166% 0.904%

Comments by SVB_Leerink_LLC for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 38.27%
Target price 388.330
Change
Ends at 25.09.26

Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $456.00 price target on the stock, down previously from $458.00.
Ratings data for VRTX provided by MarketBeat

SVB Leerink LLC 
0
Report Share
25.09.25

Stopped prediction by SVB_Leerink_LLC for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€393.15
29.12.25
€445.67
29.12.26
16.06%
12.08.26

SVB Leerink LLC 
29.12.25 50%